Susan Chi, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors (NCT05407441) | Susan Chi, MD | 2023-08-10 |
Track Susan Chi, MD automatically
Every clearance here is in the API, with alerts when new ones post.